Last Updated:
NameDesignationAppointment DateStatus
Harsh Kumar Saxena

Appointed as Whole-time director since May 2023

Whole-time director17-May-2023Current
Nagesh Kumar Middey

Appointed as Director since October 2023

Director09-Oct-2023Current
Raghuveer Adusumilli

Appointed as Director since September 2022

Director28-Sep-2022Current
Akshay Mohitkumar Shah

Appointed as Company Secretary since February 2024

Company Secretary15-Feb-2024Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Halsted Pharma Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Halsted Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address Ground Floor, Plot No.25-Hig Phase Xv, Kphb Colony, Kukatpally, Hyderabad Telangana, 500072, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Halsted Pharma Private Limited through their registered address at Ground Floor, Plot No.25-Hig Phase Xv, Kphb Colony, Kukatpally, Hyderabad Telangana, 500072, India, or via their website at halstedpharma.com. Social media links are also provided where applicable.
The current directors of Halsted Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • NAGESH KUMAR MIDDEY
  • RAGHUVEER ADUSUMILLI
  • HARSH KUMAR SAXENA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available